PCIG
URGN icon

Partners Capital Investment Group’s UroGen Pharma URGN Stock Holding History

Partners Capital Investment Group’s Portfolio URGN Stock Details URGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Hold
15,384
– – 0.01% 147
2025
Q4 		$360K Hold
15,384
– – 0.01% 139
2025
Q3 		$307K Hold
15,384
– – 0.01% 148
2025
Q2 		$211K Hold
15,384
– – 0.01% 154
2025
Q1 		$170K Buy
+15,384
New +$164K ﹤0.01% 181
2024
Q4 		– Sell
-15,384
Closed -$195K – 162
2024
Q3 		$195K Hold
15,384
– – ﹤0.01% 170
2024
Q2 		$258K Buy
+15,384
New +$219K ﹤0.01% 173
2024
Q1 		– Sell
-15,384
Closed -$231K – 261
2023
Q4 		$231K Hold
15,384
– – 0.01% 252
2023
Q3 		$216K Hold
15,384
– – 0.01% 224
2023
Q2 		$159K Buy
+15,384
New +$170K ﹤0.01% 215

Other funds holding URGN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $51.9B AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
JFG
Jefferies Financial Group New York $8.2B AUM 40.95% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $90.6B AUM 36.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return